ArticleModern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc2017

CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence.

Katherine C Kurnit et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.